Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke
After a three week trial, a jury found that PeaceHealth and Ralph Weiche, MD, acted in accordance with medical protocols in diagnosing Patricia Parker with a psychiatric condition, given her unusual symptoms.
Women less likely to receive DCD heart transplants
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.
Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.

Spatial patterns on imaging could predict Alzheimer's years before cognitive symptoms emerge

These subtle changes precede greater tissue loss related to cognitive impairment.

stroke brain dementia alzheimer's puzzle mental health

Stroke after TAVR in AFib patients: Key risk factors cardiologists should know

Reviewing a patient's medical history can help care teams select the optimal post-TAVR oral anticoagulation strategy.

doctor examines patient data on their tablet

New CVD risk calculator could end statin therapy eligibility for millions of heart patients

The new PREVENT CVD risk calculator could result in more than 16 million heart patients who are no longer eligible for preventive therapy. These significant changes “carry the potential for both benefit and harm," researchers wrote in JAMA.

Sahil Parikh, MD, FSCAI, Director of Endovascular Services at New York-Presbyterian Columbia University Irving Medical Center, and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explains there is scant clinical data on what the standard of care should be for pulmonary embolism, so it is up to clinicians to decide what is best for patients based on whether patients have mild to severe PE.

Pulmonary embolism treatments continue to evolve

There is still a lack of lack of standardized treatment protocols for pulmonary embolism. This is mainly due to limited data and a lack of reliable risk assessments, one specialist explained.

Elixir Medical DynamX sirolimus-eluting coronary bioadaptor FDA

FDA grants drug-eluting bioadaptor its breakthrough device designation

The Elixir Medical DynamX sirolimus-eluting coronary bioadaptor is designed to improve coronary luminal diameter, help restore hemodynamic modulation and reduce plaque progression in patients with de novo coronary artery lesions.

Some weight loss patients are overdosing on semaglutide, FDA warns

Compounded semaglutide injectable products are at the heart of these concerns. While the FDA says compounded drugs “can serve an important medical need for patients,” the agency does not approve these new formulations, increasing the risk of complications.

Cardiology groups push for Medicare reform in face of ‘unsustainable’ payment cuts

Nearly 130 healthcare groups are urging Congress to pass legislation that would provide relief to U.S. physicians struggling to keep up with wave after wave of payment reductions.

Edwards Lifesciences agrees to acquire JenaValve, Endotronix for $1.2B

While JenaValve is known for its Trilogy Heart Valve System, a device designed specifically to treat aortic regurgitation, Endotronix specializes in developing heart failure technologies. The news comes after Edwards sold its critical care business for $4.2 billion in June, saying it would double down on its structural heart portfolio.

Clinical

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke

Women less likely to receive DCD heart transplants

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving